Jeevan Scientific Technology L
BSE: JSTL · Healthcare Research, Analytics & Technology · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 9 companies in Healthcare Research, Analytics & Technology (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹10 cr vs borrowings ₹17 cr (FY26): borrowings are higher by ₹8 cr.
- Operating profit covered interest 4.5x in the last 12 months.
- Net loss in 3 of the last 6 quarters.
- Other income was 22% of net profit in the last 12 months.
- Dividend paid in 2 of the last 5 financial years.
- Price ₹82.25 on 2026-10-26: -12.4% from the 52-week high, +43.9% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 10 | 9 | 12 | 19 | 21 | 18 |
| EBITDA | -0 | -2 | 2 | 5 | 4 | 3 |
| OPM % | -3.8% | -20.2% | 16.7% | 27.4% | 20.2% | 16.1% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -1 | -3 | -0 | 1 | 2 | 1 |
| EPS (₹) | 0.81 | 2.03 | 0.01 | 1.52 | 0.92 | 0.44 |
| Revenue YoY | +111.6% | +107.7% | ||||
| Profit YoY | – | – |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 57 | 36 | 38 | 47 | 62 | 71 |
| EBITDA | 17 | 1 | 4 | 7 | 10 | 15 |
| Net profit | 12 | -3 | -1 | 0 | 1 | 4 |
| EPS (₹) | 8.15 | -1.96 | -0.68 | 0.04 | 0.52 | 2.89 |
| Revenue growth | -36.0% | +6.4% | +21.7% | +31.4% | – | |
| Profit growth | -124.5% | – | – | +692.3% | – | |
| Dividend / share (₹) | 0.50 | 1.20 | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +19.4% | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | +25.2% (2y) | +27.8% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 50 | 72 |
| Borrowings | 15 | 17 |
| Cash & equivalents | 0 | 10 |
| Total assets | 78 | 107 |
| Fixed assets | 23 | 25 |
| Capital work in progress | 5 | 5 |
| Investments | 0 | 3 |
| Receivables | 16 | 21 |
| Inventory | 2 | 3 |
| Payables | 3 | 6 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 10 | 0 |
| Cash from investing | -16 | -10 |
| Cash from financing | 5 | 19 |
| Capex | 16 | 8 |
| Free cash flow | -6 | -8 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 0.3% | 1.4% |
| ROCE % | 2.8% | 4.6% |
| Debtor days | 124 | 123 |
| Inventory days | 155 | 227 |
| Payable days | 305 | 459 |
| Cash conversion cycle (days) | -26 | -109 |
| Working capital days | 130 | 178 |
Peers in Healthcare Research, Analytics & Technology
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SYNGENE | ₹14,527 cr | 65.4x | 3.0x | 4.6% | 7.0% | 19.8% | +5.4% | 0.35% |
| INDGN | ₹14,472 cr | 36.0x | 4.6x | 13.9% | 17.4% | 16.2% | – | 0.33% |
| SUVEN | ₹6,917 cr | – | 11.7x | -100.5% | -59.5% | -4,155.5% | -19.3% | – |
| VIMTALABS | ₹2,185 cr | 27.4x | 4.8x | 19.1% | 23.5% | 34.3% | +8.9% | 0.20% |
| BI | ₹189 cr | 4.3x | 1.0x | 2.3% | 7.0% | 8.4% | +274.4% | – |
| TAKE | ₹154 cr | 12.1x | 5.0x | 49.8% | 20.1% | -2.0% | -34.1% | – |
| NOVELIX | ₹141 cr | 31.7x | 3.0x | 11.3% | 8.8% | 3.1% | +411.3% | – |
| JSTL | ₹102 cr | 28.5x | 1.4x | 6.1% | 9.8% | 20.5% | +19.4% | 0.97% |
| ADESHWAR | ₹23 cr | 18.0x | 0.9x | 5.5% | 10.2% | 4.9% | -12.0% | – |
All 9 companies in Healthcare Research, Analytics & Technology →
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2022-09-21 | Dividend | Dividend Rs 1.2 |
| 2021-09-07 | Dividend | Dividend Rs 0.5 |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Healthcare Research, Analytics & Technology |
| Sub-industry | Healthcare Research, Analytics & Technology |
| Symbol | JSTL |
| BSE code | 538837 |
| ISIN | INE237B01018 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.